The Scientist - Home

NIH’s plan to reduce indirect funds faced immense backlash from researchers. A federal judge ruled to extend the halt to cuts until a final decision is made.

Two researchers share their Hollywood consulting experiences of keeping science straight on the big screen.

Behavior data linked with brain circuitry could lead to effective intervention therapies for substance use.

Researchers identified new drivers in neuron remodeling, shedding light on how the brain refines neural circuitry during development.

To tackle food insecurity and climate change, scientists are tapping into ancient adaptations, engineering super crops, and designing plants from scratch.

A gene variant identified in a family and studied in a fruit fly model may offer protection against a rare X-linked seizure disorder in humans.

An NIH policy to reduce funding for indirect costs to 15 percent, although temporarily blocked nationwide, sparks widespread concern and criticism among scientists.

A machine learning tool used routine blood test reports to predict the efficacy of immune checkpoint inhibitor therapy in people with cancer.

Intermittent fasting in mice enhances natural killer cells’ cancer-fighting abilities.

Researchers identified an enzyme that helps Plasmodium-infected red blood cells adhere to the placenta, providing molecular insights into placental malaria.

Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and transplant rejection.

Sequencing bacterial genomes allows scientists to study bacterial diversity, immunity, and the human microbiome, but it requires targeted technologies.